English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Flinders University, Australia
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
4 Dec 2008
Views:
14887
Rating:
Save
Rate video
Dr. Christos Karapetis
Gene marker indicates doubling of survival time in cetuximab-treated CRC
Categories:
Colorectal & gastro
Diagnostics
Related Videos
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates...
Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA
25 Jan 2023
An overview of treatment advances in gastric cancer
Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA
18 Aug 2022
Optimum treatment strategy algorithm for mCRC
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
15 Aug 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
Tumour agnostic treatments in GI cancer
Dr Nicola Normanno and Dr Katja Schmitz
1 Feb 2022
Cancer Health Disparities Special Issue - Editorial
Prof Folakemi Odedina - University of Florida, Tampa, USA
14 Oct 2021
Radioembolisation with chemotherapy for colorectal liver metastases
Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA
28 Sep 2021
Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
14 Jun 2021
CHRONOS: Anti-EGFR rechallenge therapy with panitumumab driven by ctDNA...
Prof Andrea Sartore-Bianchi - Ospedale Niguarda, Milan, Italy
10 Jun 2021
More from
e
cancer